Cytokinetics (CYTK) Tax Rate (2010)
Cytokinetics (CYTK) posted quarterly Tax Rate of 1.41% for Q3 2010.
Powered by 
Analysis
Cytokinetics (CYTK) Tax Rate (2010) Analysis & Trends
Cytokinetics (CYTK) has reported Tax Rate for 1 consecutive years, with 1.41% the latest figure, recorded in Q3 2010.
- In Q3 2010, Tax Rate changed N/A year-over-year to 1.41%; the TTM figure through Jun 2014 stood at 0.76% (changed N/A YoY), while the FY2010 annual figure was 0.36%, down 25.0% from the prior year.
- Tax Rate was little changed at 1.41% in Q3 2010 per CYTK's latest filing.
- Across five years, Tax Rate topped out at 1.41% in Q3 2010 and bottomed at 1.41% in Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Cytokinetics | 9.63 Bn | 8.46 Bn | 25.89 Mn | - |